Clawnor, Inc.

Molly McLaughlin-Drubin

Craig M Meyers

Gary A Clawson

David Drubin

In the US about &#x2153; of college women show evidence of HPV infection. The clinical problem may be even larger in developing countries. There are currently no effective therapies for HPV infections, aside from therapeutic cone biopsies, which often are followed by recurrent, progressive lesions. Thus, pharmaceutical compositions and processes for treatment of an HPV infection are detailed. In particular, a pharmaceutical composition for inhibiting growth of a human papilloma virus-infected cell is provided which includes a peptide halomethyl ketone inhibitor of a chymotrypsin or chymotrypsin-like protease and a pharmaceutically acceptable carrier. A preferred inhibitor is AAPFcmk.

Growing community of inventors

Jamaica Plain, MA, United States of America

Molly McLaughlin-Drubin